What Happened
Getting a drug approved by the FDA can take 10 years or more. That eats into the 20-year patent term, leaving less time to recoup development costs. Congress addressed this with Patent Term Extension (PTE), which can add up to five years back onto a patent term to compensate for FDA review time.
Why It Matters
For blockbuster drugs, PTE is worth hundreds of millions of dollars. Every extra day of patent term means another day without generic competition. When patents expire, drug prices typically drop 80-90% within months. So pharmaceutical companies fight hard for every bit of extension they can get.
PTE is different from Patent Term Adjustment (PTA). PTA compensates for Patent Office delays during prosecution. PTE compensates for FDA regulatory review. They can both apply to the same patent, but they serve different purposes.
Only one patent per drug product can get PTE. Companies have to choose wisely—which patent in their family should get the extension? Usually it's the one covering the active ingredient with the longest remaining term. But sometimes method-of-use or formulation patents make more sense.
What You Should Know
If you're developing FDA-regulated products, plan for PTE from the beginning. Coordinate your patent filings with your regulatory timeline. Choose the right patent for extension. File your PTE application within 60 days of FDA approval—miss that deadline and you lose the benefit.
If you're a generic company, PTE affects your launch timing. Verify the PTE calculation—errors happen. Consider whether you can challenge the underlying patent or the PTE itself. And understand that pediatric exclusivity can add another six months on top of PTE.
PTE is a small part of patent law but a huge part of pharmaceutical strategy.